Health Care & Life Sciences » Pharmaceuticals | Ahn-Gook Pharmaceutical Co. Ltd.

Ahn-Gook Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Ahn-Gook Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Core Equity Portfolio
61,452
0.47%
4,081
0%
04/30/2018
DFA Emerging Markets Small Cap Series
58,793
0.45%
0
0.01%
01/31/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
4,803
0.04%
0
0%
12/31/2017
Symmetry Moderate Growth Portfolio
4,792
0.04%
58
0%
06/30/2018
Symmetry Growth Portfolio
4,781
0.04%
170
0.01%
06/30/2018
DFA Emerging Markets Social Core Equity Portfolio
3,399
0.03%
0
0%
04/30/2018
DFA World (ex-US) Targeted Value Portfolio
2,130
0.02%
0
0.01%
04/30/2018
John Hancock II - Emerging Markets Fund
1,780
0.01%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
1,612
0.01%
0
0%
04/30/2018
Dimensional Funds II Plc - Emerging Markets Targeted Value Fd.
1,554
0.01%
1,554
0.01%
05/31/2017

About Ahn-Gook Pharmaceutical Co.

View Profile
Address
613 Siheung-daero
Seoul SL 07445
Korea, Republic Of
Employees -
Website http://ahn-gook.com
Updated 09/14/2018
Ahn-Gook Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include health function food, medical supplement, quasi-drugs, over-the-counter drugs, ethical drugs, elatin solution and tablet, losastar tablet, suprafen tablet, and recommended products such as tobicom-S soft capsule, levotension tablet, and tobicomKid Q-10 chewable tablet. The company was founded by Noh Jong-Hyeong on September 16, 1955 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.